Navigation Links
Alzheimer's Drug Shows Promise in Fighting Cancer

LOS ANGELES, April 17, 2007 /PRNewswire/ -- Researchers from the Barbara Ann Karmanos Cancer Institute in Detroit, MI presented strong evidence today that an antibiotic typically prescribed for Alzheimer's patients could be effective in eventually treating certain types of cancers.

Q. Ping Dou, Ph.D., leader, Prevention Program at Karmanos, and members of his lab announced the findings of their study showing that the drug Clioquinol (CQ) appears to have an anti-tumor effect in mice bearing human prostate cancer cells. The announcement was made at the American Association of Cancer Research (AACR) annual meeting in Los Angeles, CA.

Dr. Dou and his team turned to the copper-binding compound CQ after discovering that prostate, breast, brain, colon and lung tumor tissue often have a higher level of copper than normal tissue. According to Dr. Dou, this led his team to investigate whether cancers with high levels of copper can lead to targeted treatment.

Karmanos researchers found that after binding CQ to the copper in prostate tumor tissue, the drug induces cell death in human prostate cancer cells.

According to Dr. Dou, his lab will take this information and work with Karmanos clinicians to create a treatment selectively targeting the copper found in tumors.

"We want to find out if we can target cancers that express high levels of copper," says Dr. Dou. "We hope to discover a compound that promotes tumor-killing activity."

The AACR was founded in 1907 by a group of eleven physicians and scientists interested in research, "to further the investigation and spread the knowledge of cancer." Today, AACR accelerates progress toward the prevention and cure of cancer by promoting research, education, communication, and advocacy.

Based in midtown Detroit, the Barbara Ann Karmanos Cancer Institute is committed to a future free of cancer. The Institute is one of 39 National Can
'"/>




Page: 1 2

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. At the 2007 Alzheimers Association International Conference on the Prevention of Dementia - Neurochems U.S. Principal Investigator Presents Update on Tramiprosate (Alzhemed)
5. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
6. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
7. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
8. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
9. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
10. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
11. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alzheimer Drug Shows Promise Fighting Cancer
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... MTEC , the leading online Medical Transcription and ... of its NexGen Speech Recognition Editing and Medical Transcription ... documentation expertise, MTEC is moving their curriculum to the ... step in this important industry migration and is being ...
... 9, 2010 Biodel Inc. (Nasdaq: BIOD ) today ... September 30, 2010. Fourth Quarter and Fiscal Year ... the quarter ended September 30, 2010 of $8.1 million, or $0.31 ... $0.44 per share, for the quarter ended September 30, 2009. ...
Cached Medicine Technology:MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program 2Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... in those who listened just a few hours a day ... for a few hours a day can help boost a ... study of 54 patients who,d suffered a stroke of the ... who listened to music for a few hours a day ...
... Does exposure of baby boys -- in utero or in ... natural estrogens, predispose them to prostate cancer later in life? ... Illinois at Chicago researcher and her colleague aims to answer ... it may occur. , Gail Prins, professor of urology at ...
... This release is available in French . , ... battle in the fight against age-related macular degeneration, or AMD, ... international team, led by researchers at Sainte-Justine Hospital and the ... the dry form of AMD. , In the February ...
... an active material could be used to remove toxic ... much more effectively and at lower cost than conventional ... current issue of the International Journal of Nanotechnology. , ... Wark Research Institute, at the University of South Australia, ...
... Feb. 20 HIV/AIDS is still a,taboo topic among ... to change this. For Dinah Ayna, talking about HIV ... is a challenging, yet a rewarding,part of her daily ... are 3.5 million Arab,Americans in the U.S. One-third live ...
... 20 LifeSync Corporation is,pleased to announce the ... of Research and Development. Dr. Phelps, who will ... responsible for leading all,product design and development at ... Georgia Electronic Design Center (GEDC),at the Georgia Institute ...
Cached Medicine News:Health News:Music Therapy Improves Stroke Outcomes 2Health News:Grant to study if early BPA exposure leads to late prostate cancer 2Health News:AMD discovery: New hope for treatment of vision loss 2Health News:Cleaner water through nanotechnology 2Health News:Breaking Down Barriers: A Woman's Path to Reducing HIV Stigma in the Arab American Community 2Health News:LifeSync Hires Dr. Mark Phelps to Lead Research & Development 2
... The Nightingale Monitoring System™ expands hospital-grade monitoring ... of subacute care and disease state management. ... ability to encompass a full range of ... patients inside the hospital, to periodic monitoring ...
... FlexNet adds wireless capability to ... This expands the Flexible Monitoring concept ... patient information from anywhere to anywhere. ... ambulatory wireless monitors and hardwired and ...
... Propaq CS makes the ... Propaq CS even more ... Symbol Technologies, the Wireless ... wireless ethernet Local Area ...
... Welch Allyn Vital Signs Monitor ... clinical areas that don't require ... to use, each monitor comes ... and optional features include Nellcor ...
Medicine Products: